Navigation Links
Intarcia Therapeutics Appoints Nancy Thornberry to Board of Directors
Date:12/2/2013

BOSTON, Dec. 2, 2013 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the appointment of Nancy Thornberry to its Board of Directors. Nancy's exceptional 34-year career at Merck demonstrates the power of her insight, innovation and ability to achieve competitively superior results in the pharmaceutical industry – particularly in diabetes. This makes an excellent match for the development and business opportunity expected with ITCA 650 (a breakthrough once- or twice-yearly GLP-1 for type 2 diabetes that is currently in Phase 3 clinical trials), as well as the Company's longer-term pipeline. Nancy's guidance and input will be of immediate benefit helping Intarcia chart the best course forward for ITCA 650 to bring the product to market and to help realize its full potential to improve treatment outcomes for appropriate patients with type 2 diabetes around the world.

"Nancy is an industry leader and icon of pharmaceutical innovation, having personally led the discovery, and subsequently the global franchise aspects, for a novel diabetes medicine and combinations that are fundamentally improving medical outcomes for type 2 diabetics around the world," said Kurt Graves, Chairman, President and CEO of Intarcia. "It's very exciting to have someone of Nancy's caliber and deep expertise in diabetes and metabolism join our Board and work shoulder-to-shoulder with us as we strive to bring our once-yearly and potentially game-changing medicine, ITCA 650, to patients suffering from type 2 diabetes. Our Board and management team are all extremely excited to have Nancy become our newest member of our Board of Directors."

Nancy Thornberry began her distinguished career at Merck Research Laboratories in 1979 as a Biochemist, and steadily assumed positions of increasing responsibility – distinguishing herself along the way with
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes
2. Intarcia Announces Expanded Appointment for Kurt Graves as Chairman, President and Chief Executive Officer
3. Scientists develop way to successfully give nanoparticle therapeutics orally
4. Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Dose-Ranging Field Study in Client-Owned Dogs with Osteoarthritis
5. Northwest Biotherapeutics Announces Pricing Of Public Offering Of Common Stock And Warrants
6. Aratana Therapeutics to Present at Two Upcoming Investor Conferences
7. Jade Therapeutics Elects Veteran Life Science Entrepreneur Dinesh Patel, Ph.D., to its Board of Directors
8. Argos Therapeutics Presents Data Showing Memory T Cell Expansion After Administration of Fully Personalized Immunotherapy Correlates with Overall Survival Benefit in Patients with Metastatic Renal Cell Carcinoma
9. Global Aptamers Market Technology Trend Analysis Market Report 2013-2018: Therapeutics, Diagnostics, Biosensors, Biomarker/Drug Discovery & Applications
10. Acquisitions, Project Announcements & Trend Analysis News for Oxygen Biotherapeutics, Glu Mobile, Cisco Systems, Barrick Gold, CVS Caremark
11. Convoy Therapeutics Appoints Clinical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... Investor-Edge has initiated coverage ... GENE ), Agilent Technologies Inc. (NYSE: ... TMO ), Sequenom Inc. (NASDAQ: SQNM ), ... research report on Genetic Technologies can be accessed ... 2015, the NASDAQ Composite ended at 4,941.42, down ...
(Date:5/1/2015)... DALLAS , May 1, 2015 ... report "Antibody Production Market by Product (Equipment, Consumables), by ... (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis ... the report studies the global Antibody Production Market ... This market is expected to reach $2.572 Billion ...
(Date:4/30/2015)... Blythewood, South Carolina (PRWEB) May 01, 2015 ... steam system services, is extremely proud to announce that ... have been named as a winner of a Queen’s ... business success for the design and manufacture of a ... is the revolutionary alternative to traditional steam flow ...
(Date:4/30/2015)... 30, 2015   Tamir Biotechnology , a leading ... on its Ebola antiviral therapy program. ... is currently being evaluated and considered by a number ... Ebola. During the first quarter of 2015, the company ... Accelerate The Evaluation of Potential Treatments and Vaccines For ...
Breaking Biology Technology:Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 2Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 3Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 4Life Sciences Tools and Services Stocks on our Radar -- Genetic Technologies, Agilent Technologies, Thermo Fisher Scientific, Sequenom, and PerkinElmer 5Antibody Production Market worth $2.572 Billion by 2019 2Antibody Production Market worth $2.572 Billion by 2019 3Antibody Production Market worth $2.572 Billion by 2019 4Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 2Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 4
... In LESS Instrumentation Is Selected for Industry Leader LESS ... Jan. 29 Cambridge Endo, a pioneer in the ... Surgery or SPA) market, is pleased to announce that ... industry leaders selected to be on a LESS panel ...
... of first-in-class multivalent therapies for cancerREDWOOD SHORES, Calif., Jan. ... it has entered into a $24 million private placement ... this financing, investments will be made in three tranches: ... December 31, 2009 and $8 million before December 31, ...
... evolves content and advertising offerings to life science community , ... ... to its online community for life science careers and industry resources. ... a partnership with the Journal of Visualized Experiments (JoVE)., , , ...
Cached Biology Technology:Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009 2Omnitura Therapeutics Announces Private Placement Financing 2BioSpace Partners with Journal of Visualized Experiments (JoVE) to Offer Peer-Reviewed Scientific Video Content on BioSpace.com 2BioSpace Partners with Journal of Visualized Experiments (JoVE) to Offer Peer-Reviewed Scientific Video Content on BioSpace.com 3
(Date:4/13/2015)... , April 13, 2015  higi, a leading ... ways to more fully engage with their communities around ... industry-leading, privacy protected and secure API.  ... enables the most accessible, affordable, and convenient vehicle to ... The API will allow ...
(Date:4/8/2015)... 2015  Infinisource, a leading provider of SaaS-based Human ... a leading supplier of biometric identification and security ... most advanced biometrically-enabled time clock, the companies announced ... is setting a bold, new standard for the ... small and mid-size employer. When connected to the ...
(Date:4/2/2015)... , April 2, 2015 At its ... Salt Lake City , the American College of ... five new directors to its Board.  Members of the ... ACMG and for forming and advancing its policies and ... genetics profession. "It,s an eventful time in ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... According to the World Bank, China has one of ... only to the United States in emissions of carbon dioxide, ... home to 20 of the worlds 30 most air-polluted cities. ... acid rain and water pollution, scientists at UC Riverside and ...
... the structure of human bones is vastly different than ... how some debilitating bone disorders are treated. Researchers ... in Newmarket, and the BAM Federal Institute of Materials ... toughness and stiffness of bone is predominantly due to ...
... Ninety-seven years after an American was hanged in London in ... British history, forensic science at Michigan State University is producing ... Crippen was hanged for murdering and dismembering his showgirl wife, ... the police in hot pursuit. Loaded with enough sordid details ...
Cached Biology News:UC-Riverside partners with Chinese university to address China's environmental problems 2UC-Riverside partners with Chinese university to address China's environmental problems 3New research on structure of bones raises questions for treatment of osteoporosis 2Science casts doubt on famous British murder case 2Science casts doubt on famous British murder case 3